by Jordana Choucair | Apr 28, 2022 | Opioid/Substance Use Disorders
Members of the House Oversight and Reform Committee questioned McKinsey & Company about its potential role in exacerbating the opioid epidemic. The hearing comes after the committee released a report alleging a years-long conflict of interest stemming from...
by Jordana Choucair | Apr 28, 2022 | Payers
According to a new report from Moody’s Investors Service, insurers have a significant opportunity to drive mental and behavioral health costs down. The report notes that private insurance accounts for 27.7 percent of emergency department visits across the five...
by Jordana Choucair | Apr 28, 2022 | Payers
The U.S. Health and Human Services Department Office of the Inspector General (OIG) released a report indicating that Medicare Advantage plans improperly deny millions of reimbursement claims and authorization requests for medically necessary care. The OIG found...
by Jordana Choucair | Apr 28, 2022 | Public Health/Prevention
Dr. Anthony Fauci said that the U.S.is in a “transition phase” of the COVID-19 pandemic. He noted that while COVID-19 cases and hospitalizations are trending up again, it’s not anywhere near the rise we saw over the winter with the Omicron wave and that fewer...
by Jordana Choucair | Apr 27, 2022 | D.C. News
Senator Joe Manchin said health care policy priorities pushed by Democrats won’t go anywhere without changes to the tax code, but cited prescription drug pricing as an area of opportunity if lawmakers “fix the financial situation.” Manchin said he...
by Jordana Choucair | Apr 27, 2022 | Health IT
According to a new study in JAMA Network Open, telehealth generally didn’t lead to duplicative care in late 2020. The study found that patients treated for most acute conditions via telehealth were as likely or slightly more likely to need a follow-up visit as...
Recent Comments